US FDA denied two formal requests for dispute resolution related to sotagliflozin after issuing a complete response letter to original application holder Sanofi . • Source: Shutterstock
Learn what's happening at the US FDA. On the go.
Derrick Gingery and the team bring you a weekly "Drug Fix".
